ES8507449A1 - Procedimiento de obtencion del 3-(3-hidroxibutoxi)-1-butanol - Google Patents
Procedimiento de obtencion del 3-(3-hidroxibutoxi)-1-butanolInfo
- Publication number
- ES8507449A1 ES8507449A1 ES532802A ES532802A ES8507449A1 ES 8507449 A1 ES8507449 A1 ES 8507449A1 ES 532802 A ES532802 A ES 532802A ES 532802 A ES532802 A ES 532802A ES 8507449 A1 ES8507449 A1 ES 8507449A1
- Authority
- ES
- Spain
- Prior art keywords
- butanol
- hydroxybutoxy
- pharmaceutical compositions
- pure
- methylpropoxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C43/00—Ethers; Compounds having groups, groups or groups
- C07C43/02—Ethers
- C07C43/03—Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
- C07C43/04—Saturated ethers
- C07C43/13—Saturated ethers containing hydroxy or O-metal groups
- C07C43/132—Saturated ethers containing hydroxy or O-metal groups both carbon chains being substituted by hydroxy or O-metal groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C43/00—Ethers; Compounds having groups, groups or groups
- C07C43/02—Ethers
- C07C43/03—Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
- C07C43/14—Unsaturated ethers
- C07C43/164—Unsaturated ethers containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C43/00—Ethers; Compounds having groups, groups or groups
- C07C43/02—Ethers
- C07C43/03—Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
- C07C43/14—Unsaturated ethers
- C07C43/178—Unsaturated ethers containing hydroxy or O-metal groups
- C07C43/1785—Unsaturated ethers containing hydroxy or O-metal groups having more than one ether bound
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Gastroenterology & Hepatology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
PROCEDIMIENTO PARA LA OBTENCION DEL 3-(3-HIDROXIBUTOXI)-1-BUTANOL, Y DE SUS FORMAS ESTEROISOMERAS.COMPRENDE LAS SIGUIENTES OPERACIONES: PRIMERA, A PARTIR DE UNA MEZCLA DE ISOMEROS, DE FORMULAS GENERALES (I), (II) Y (III), SE ELIMINAN LOS COMPUESTOS INSATURADOS MEDIANTE SUCESIVOS LAVADOS CON HIDROCARBUROS ALIFATICOS, PREFERENTEMENTE CON ETER DE PETROLEO; SEGUNDA, SE SEPARAN LOS COMPUESTOS DE FORMULA (II) DE LA MEZCLA ISOMERICA, MEDIANTE REACCION SELECTIVA CON CLORURO DE TRIFENILMETILO, EN PRESENCIA DE TRIETILAMINA Y DE CANTIDADES CATALITICAS DE 4-DIMETILAMINO-PIRIDINA; Y POR ULTIMO, SE SEPARAN LOS DIASTOMEROS DEL COMPUESTO DE FORMULA GENERAL (II), MEDIANTE ACILACION CON UN HALURO DE ACILO, TAL COMO EL CLORURO DE P-NITROBENZOILO.DE APLICACION EN LA PROFILAXIS Y TERAPEUTICA DE LA CALCULOSIS BILIAR.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT21352/83A IT1164254B (it) | 1983-05-30 | 1983-05-30 | 3-(3-idrossibutossi)-1-butanolo e suo metodo di preparazione |
Publications (2)
Publication Number | Publication Date |
---|---|
ES532802A0 ES532802A0 (es) | 1985-10-01 |
ES8507449A1 true ES8507449A1 (es) | 1985-10-01 |
Family
ID=11180528
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES532802A Expired ES8507449A1 (es) | 1983-05-30 | 1984-05-25 | Procedimiento de obtencion del 3-(3-hidroxibutoxi)-1-butanol |
Country Status (8)
Country | Link |
---|---|
US (1) | US4584321A (es) |
JP (1) | JPS604146A (es) |
BE (1) | BE899790A (es) |
DE (1) | DE3419947A1 (es) |
ES (1) | ES8507449A1 (es) |
FR (1) | FR2547813B1 (es) |
GB (1) | GB2142623B (es) |
IT (1) | IT1164254B (es) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0534451Y2 (es) * | 1988-06-20 | 1993-08-31 | ||
US6410802B1 (en) | 1999-04-01 | 2002-06-25 | Esperion Therapeutics, Inc. | Methods for synthesizing ether compounds and intermediates therefor |
IL155246A0 (en) | 2000-10-11 | 2003-11-23 | Esperion Therapeutics Inc | Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses |
EP1326822A2 (en) | 2000-10-11 | 2003-07-16 | Esperion Therapeutics Inc. | Ketone compounds and compositions for cholesterol management and related uses |
US6713507B2 (en) | 2000-10-11 | 2004-03-30 | Esperion Therapeutics, Inc. | Ether compounds and compositions for cholesterol management and related uses |
US20040122091A1 (en) * | 2000-10-11 | 2004-06-24 | Esperion Therapeutics, Inc. | Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses |
CN101426763A (zh) | 2000-10-11 | 2009-05-06 | 埃斯佩里安医疗公司 | 用于胆固醇治疗和相关应用的硫化物和二硫化物化合物和组合物 |
US7304093B2 (en) * | 2000-10-11 | 2007-12-04 | Esperion Therapeutics, Inc. | Ketone compounds and compositions for cholesterol management and related uses |
US20040192771A1 (en) * | 2001-10-11 | 2004-09-30 | Dasseux Jean-Louis Henri | Ether compounds and compositions for cholesterol management and related uses |
US20050020694A1 (en) * | 2001-10-11 | 2005-01-27 | Dasseux Jean-Louis Henri | Sulfide and disulfide compounds and compositions for cholesterol management and related uses |
US20040204502A1 (en) * | 2001-10-11 | 2004-10-14 | Dasseux Jean-Louis Henri | Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses |
CA2480415A1 (en) * | 2002-04-10 | 2003-10-23 | Esperion Therapeutics, Inc. | Mimics of acyl coenzyme-a, compositions thereof, and methods of cholesterol management and related uses |
ES2594340T3 (es) | 2003-01-23 | 2016-12-19 | Esperion Therapeutics Inc. | Compuestos de hidroxilo y composiciones para el control del colesterol y utilizaciones correspondientes |
EP1701931B1 (en) | 2003-12-24 | 2018-10-10 | Esperion Therapeutics, Inc. | Ketone compounds and compositions for cholesterol management and related uses |
CN103848726B (zh) * | 2012-12-09 | 2017-09-05 | 河北凯盛医药科技有限公司 | 一种高纯度二羟二丁基醚及其制备方法 |
CN103304383B (zh) * | 2013-06-18 | 2015-04-08 | 重庆医科大学 | 保胆健素的新合成方法 |
CN103333057A (zh) * | 2013-06-24 | 2013-10-02 | 大连理工大学 | 一种二羟基二丁醚的制备方法 |
CN103319316B (zh) * | 2013-06-24 | 2015-06-10 | 大连理工大学 | 一种二羟基二丁醚的绿色制备方法 |
CN104230674A (zh) * | 2014-08-28 | 2014-12-24 | 成都邦泽生物医药科技有限公司 | 一种二羟基二丁醚的制备方法 |
CN107530307A (zh) | 2015-03-13 | 2018-01-02 | 艾斯柏伦治疗公司 | 包含etc1002和依泽替米贝的固定剂量组合和制剂以及治疗心血管疾病或降低心血管疾病风险的方法 |
MA41793A (fr) | 2015-03-16 | 2018-01-23 | Esperion Therapeutics Inc | Associations de doses fixes comprenant du etc1002 et une ou plusieurs statines permettant de traiter ou de réduire un risque cardiovasculaire |
CN112437765A (zh) | 2019-06-21 | 2021-03-02 | 艾斯柏伦治疗公司 | 贝派地酸的盐形式及其使用方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT957008B (it) * | 1967-11-09 | 1973-10-10 | Luso Farmaco Inst | Processo per la preparazione di eteri simmetrici di glicoli re canti ossidrili primari e secon dari |
DE2218935C3 (de) * | 1972-04-19 | 1980-01-31 | Basf Ag, 6700 Ludwigshafen | Verfahren zur Herstellung von wäßrigen Lösungen von N-Vinylpyrrolidonpolymerisaten |
-
1983
- 1983-05-30 IT IT21352/83A patent/IT1164254B/it active Protection Beyond IP Right Term
-
1984
- 1984-04-23 US US06/603,134 patent/US4584321A/en not_active Expired - Lifetime
- 1984-05-03 GB GB08411356A patent/GB2142623B/en not_active Expired
- 1984-05-25 ES ES532802A patent/ES8507449A1/es not_active Expired
- 1984-05-28 JP JP59108268A patent/JPS604146A/ja active Granted
- 1984-05-28 DE DE19843419947 patent/DE3419947A1/de active Granted
- 1984-05-30 BE BE0/213036A patent/BE899790A/fr not_active IP Right Cessation
- 1984-05-30 FR FR848408571A patent/FR2547813B1/fr not_active Expired
Also Published As
Publication number | Publication date |
---|---|
IT8321352A0 (it) | 1983-05-30 |
FR2547813B1 (fr) | 1989-01-27 |
JPS604146A (ja) | 1985-01-10 |
DE3419947C2 (es) | 1987-11-26 |
JPS6241702B2 (es) | 1987-09-04 |
ES532802A0 (es) | 1985-10-01 |
DE3419947A1 (de) | 1984-12-06 |
BE899790A (fr) | 1984-11-30 |
US4584321A (en) | 1986-04-22 |
FR2547813A1 (fr) | 1984-12-28 |
IT8321352A1 (it) | 1984-11-30 |
IT1164254B (it) | 1987-04-08 |
GB2142623A (en) | 1985-01-23 |
GB8411356D0 (en) | 1984-06-06 |
GB2142623B (en) | 1987-04-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES8507449A1 (es) | Procedimiento de obtencion del 3-(3-hidroxibutoxi)-1-butanol | |
ES8307794A1 (es) | Un procedimiento para la preparacion de agentes antifugicos triazolicos. | |
AU4323693A (en) | Enniatines and enniatine derivates used to control endoparasites | |
ES8401009A1 (es) | Procedimiento para la preparacion de 2-(p-isobutil-fenil)propionato de 2-hidroxi-3-(o-metoxi-fenoxi)propilo. | |
GR77915B (es) | ||
AU8599091A (en) | Antimicrobial agents as well as substituted 2-cyclohexan-1-y1-amine derivatives and their preparation | |
MY136249A (en) | Phenylethanolamine compounds as anti-obesity agents | |
ES8608535A1 (es) | Procedimiento para preparar una composicion para el tratamiento topico de acne | |
ES8702371A1 (es) | Un procedimiento para preparar nuevos derivados de 6-(4-fenilo sustituido -3(2h) piradazinona. | |
DE3172298D1 (en) | Pharmaceutical compositions | |
ES8205759A1 (es) | Un procedimiento para la preparacion de aminopropenol y pro-pano nitrilos 2 sustituidos. | |
ES8105053A1 (es) | Procedimiento para la preparacion de mezclas de aclaradores opticos | |
AU7345391A (en) | Derivative of beta-phenylisoserine, preparation and utilisation thereof | |
MY137475A (en) | Chemical compounds. | |
AU654300B2 (en) | 7-acyl-3-(substituted carbamoyloxy)cephem compounds and process for their preparation | |
ES8604520A1 (es) | Procedimiento para preparar derivados de 2(1h)-piridona | |
DE3470313D1 (en) | Antibiotic, its preparation and its use | |
ES2006488A6 (es) | Un procedimiento para la preparacion de un glicosido de antraciclina. | |
GR78622B (es) | ||
ZA874470B (en) | New tetrahydrobenzothiazoles,and the preparation and use thereof | |
ES8501734A1 (es) | Un procedimiento para preparar derivados de cicloalquenilo | |
ES8204980A1 (es) | Procedimietno para la preparacion de salicilato de lidocaina monohidrato. | |
ES8206544A1 (es) | Procedimiento para la preparacion de 4-carbamoiloxi-oxaza- fosforinas | |
HUT75343A (en) | Anthracycline disaccharides, process for their preparation, and pharmaceutical compositions containing the said compds. | |
ES8400397A1 (es) | Un procedimiento para la preparacion de un nuevo peptido activo. |